Novartis Australia Building Shortlisted for the Architizer A+ Awards
The Novartis Australia headquarters has been shortlisted as an A+ Awards finalist for the Commercial Office Mid Rise category. The project is competing against international competition in the category, including SOM, JKMM Architects, Olson Kundig and Hooba design for the two most sought-after awards: the Architizer A+ Jury Award and the Architizer A+ Popular Choice Award.
Designed by HDR, the Australian Novartis head office brings together associates from across Alcon, Novartis Pharmaceuticals and Sandoz with a focus on increasing collaboration to drive the company's culture of innovation.
The building is characterised by two conceptual directions: caring for patients and science-based innovation. The scientific finds its expression in the form of the slender glass rectangle of the office floor, projecting from the sloping site. It is intersected by the human element, revealed by a contrasting language of timber and aluminum curved forms that shape the core and collaboration spaces at the heart of the building. The interaction between these two components — a building of clean lines and precise transparent forms, supported by a series of warm curved elements — clearly expresses Novartis' humanist mission and a culture of innovation.
Now in its fourth year, the Architizer A+ Awards is the largest awards program focused on promoting and celebrating the year's best architecture and products. Its mission is to nurture the appreciation of meaningful architecture in the world and champion its potential for a positive impact on everyday life.